DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,113 | +2.0% | 20,464 | +1.9% | 1.78% | +0.8% |
Q1 2024 | $5,013 | +9.9% | 20,074 | +1.8% | 1.77% | +1.0% |
Q4 2023 | $4,562 | -4.8% | 19,719 | +2.1% | 1.75% | -14.4% |
Q3 2023 | $4,794 | +3.8% | 19,319 | +0.4% | 2.04% | +11.3% |
Q2 2023 | $4,618 | -4.1% | 19,239 | +0.7% | 1.83% | -10.8% |
Q1 2023 | $4,815 | -2.0% | 19,104 | +3.2% | 2.05% | -7.2% |
Q4 2022 | $4,915 | -99.9% | 18,514 | -1.5% | 2.21% | -7.5% |
Q3 2022 | $4,855,000 | +4.8% | 18,799 | +2.8% | 2.39% | +10.4% |
Q2 2022 | $4,634,000 | -25.5% | 18,279 | -13.7% | 2.17% | -9.3% |
Q1 2022 | $6,216,000 | -11.3% | 21,189 | -0.5% | 2.39% | -3.7% |
Q4 2021 | $7,005,000 | +3.2% | 21,289 | -4.5% | 2.48% | -5.3% |
Q3 2021 | $6,787,000 | +10.6% | 22,293 | -2.5% | 2.62% | +13.2% |
Q2 2021 | $6,138,000 | +18.8% | 22,869 | -0.4% | 2.32% | +16.8% |
Q1 2021 | $5,166,000 | +1.3% | 22,954 | -0.0% | 1.98% | -4.0% |
Q4 2020 | $5,101,000 | +2.0% | 22,964 | -1.1% | 2.07% | -7.6% |
Q3 2020 | $4,999,000 | +19.9% | 23,214 | -14.6% | 2.24% | +16.2% |
Q4 2019 | $4,170,000 | +15.4% | 27,174 | +8.6% | 1.92% | +4.5% |
Q3 2019 | $3,612,000 | +1.9% | 25,016 | +0.8% | 1.84% | +0.1% |
Q2 2019 | $3,546,000 | +6.3% | 24,816 | -1.8% | 1.84% | +4.7% |
Q1 2019 | $3,337,000 | +20.5% | 25,266 | +1.6% | 1.76% | +15.1% |
Q4 2018 | $2,770,000 | +21.2% | 24,865 | +18.2% | 1.53% | +26.7% |
Q3 2018 | $2,286,000 | +21.1% | 21,035 | +9.9% | 1.20% | +11.1% |
Q2 2018 | $1,888,000 | +11.1% | 19,135 | +10.3% | 1.08% | +4.8% |
Q1 2018 | $1,699,000 | +7.1% | 17,345 | +1.4% | 1.04% | +14.5% |
Q4 2017 | $1,587,000 | -99.9% | 17,100 | +5.4% | 0.90% | +4.4% |
Q3 2017 | $1,391,782,000 | +5.9% | 16,225 | +4.2% | 0.87% | +3.1% |
Q2 2017 | $1,314,374,000 | +7.5% | 15,575 | +9.3% | 0.84% | +8.0% |
Q1 2017 | $1,222,223,000 | +106551.2% | 14,250 | 0.0% | 0.78% | +6.4% |
Q4 2016 | $1,146,000 | +12.8% | 14,250 | +12.2% | 0.73% | +10.4% |
Q2 2016 | $1,016,000 | +4.1% | 12,695 | +25.4% | 0.66% | +7.6% |
Q1 2016 | $976,000 | +52.5% | 10,120 | +36.8% | 0.62% | +33.4% |
Q4 2015 | $640,000 | – | 7,395 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |